Integrated Core Strategies (US) LLC holds 5.3% of Fortress Biotech, equal to 1,778,133 common shares. The holder certified that the position was not acquired or maintained to change or influence Fortress Biotech’s control, giving investors a defined passive-ownership status rather than an expressly stated control objective.
Key Highlights
- Fortress Biotech common stock carries a Par Value of $0.001 per share.
- The joint filing agreement among the reporting parties is dated August 31, 2026.
- Integrated Core Strategies (US) LLC reports a 5.3% ownership position in Fortress Biotech, representing 1,778,133 common shares.
Fortress Biotech, Inc. (NASDAQ: FBIO) has a reported 5.3% ownership position held by Integrated Core Strategies (US) LLC, representing 1,778,133 common shares. The position is reported through a Schedule 13G under Rule 13d-1(c). The certification states that the securities were not acquired or held to change or influence control of Fortress Biotech.
Millennium Entities Listed
The filing says the reported information should not, by itself, be treated as an admission of beneficial ownership by those parties of securities held by the entities. Fortress Biotech’s reported security is common stock with a par value of $0.001 per share.
Passive Investment Intent
The reporting parties certified that the securities were not acquired or held for the purpose of changing or influencing Fortress Biotech’s control. The ownership disclosure therefore identifies a passive position rather than an expressly stated control objective.
Joint Agreement Dated August 31
The reporting parties entered into a Joint Filing Agreement dated August 31, 2026. The agreement authorizes the Schedule 13G to be submitted on behalf of each named person and entity. Integrated Core Strategies (US) LLC is shown c/o Millennium Management LLC at that address.
FAQs
Q: What percentage of Fortress Biotech does Integrated Core Strategies own?
A: Integrated Core Strategies (US) LLC reports a 5.3% ownership position in Fortress Biotech, representing 1,778,133 common shares. The position is disclosed as a passive investment without an expressly stated objective to change or influence control.
Q: Is the Fortress Biotech stake activist or passive?
A: The ownership position is passive. The reporting parties certified that the securities were not acquired or held to change or influence Fortress Biotech’s control.
Q: Which Millennium entities reported Fortress Biotech ownership?
A: Millennium Management LLC and Millennium Group Management LLC each report 5.3% ownership. Israel A. Englander is also listed with 5.3% and 1,778,561 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.